Current Diagnosis and Management of Primary Chylomicronemia
暂无分享,去创建一个
H. Daida | K. Matsuki | S. Yokoyama | S. Ishibashi | M. Harada‐Shiba | Toshio Hayashi | H. Okazaki | T. Gotoda | D. Masuda | M. Hori | M. Ogura | Kyoko Inagaki | Daisaku Masuda
[1] Jeffrey B. Boord,et al. Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline. , 2020, The Journal of clinical endocrinology and metabolism.
[2] S. Young,et al. Chylomicronemia from GPIHBP1 autoantibodies , 2020, Journal of Lipid Research.
[3] D. Gaudet,et al. Evinacumab for Homozygous Familial Hypercholesterolemia. , 2020, The New England journal of medicine.
[4] D. Gaudet,et al. Dissection of Clinical and Gene Expression Signatures of Familial versus Multifactorial Chylomicronemia , 2020, Journal of the Endocrine Society.
[5] M. Borgnia,et al. The structure of helical lipoprotein lipase reveals an unexpected twist in lipase storage , 2020, Proceedings of the National Academy of Sciences.
[6] R. Hegele,et al. Practical definitions of severe versus familial hypercholesterolaemia and hypertriglyceridaemia for adult clinical practice. , 2019, The lancet. Diabetes & endocrinology.
[7] I. Minicocci,et al. Spectrum of Mutations and Long-Term Clinical Outcomes in Genetic Chylomicronemia Syndromes. , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[8] D. Gaudet,et al. Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome. , 2019, The New England journal of medicine.
[9] W. Sasiela,et al. Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia , 2019, Circulation.
[10] R. Hegele,et al. Chylomicronemia: Differences between familial chylomicronemia syndrome and multifactorial chylomicronemia. , 2019, Atherosclerosis.
[11] Sekar Kathiresan,et al. Genetics of Common, Complex Coronary Artery Disease , 2019, Cell.
[12] Jian-Min Chen,et al. Identification of a novel and heterozygous LMF1 nonsense mutation in an acute pancreatitis patient with severe hypertriglyceridemia, severe obesity and heavy smoking , 2019, Lipids in Health and Disease.
[13] S. Young,et al. Lipoprotein lipase is active as a monomer , 2019, Proceedings of the National Academy of Sciences.
[14] Takeshi Kimura,et al. Critical Role of SREBP-1c Large-VLDL Pathway in Environment-Induced Hypertriglyceridemia of Apo AV Deficiency , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[15] R. Hegele,et al. The role of genetic testing in dyslipidaemia. , 2019, Pathology.
[16] Xinjiang Zhang,et al. A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient , 2019, Journal of atherosclerosis and thrombosis.
[17] R. Hegele,et al. Update on the diagnosis, treatment and management of rare genetic lipid disorders. , 2019, Pathology.
[18] S. Kihara,et al. Juvenile‐onset systemic lupus erythematosus with severe hypertriglyceridemia induced by anti‐apolipoprotein C‐II antibody , 2019, Pediatrics international : official journal of the Japan Pediatric Society.
[19] Deepak L. Bhatt,et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia , 2019, The New England journal of medicine.
[20] Faisal Inayat,et al. Hypertriglyceridemic Pancreatitis Treated with Insulin Therapy: A Comparative Review of 34 Cases , 2018, Cureus.
[21] Faisal Inayat,et al. Hypertriglyceridemic Pancreatitis: Is Insulin Monotherapy A Feasible Therapeutic Option? , 2018, Cureus.
[22] L. Cho,et al. Familial Chylomicronemia Syndrome: Clinical Characteristics and Long-Term Cardiovascular Outcomes. , 2018, Journal of the American College of Cardiology.
[23] J. Borén,et al. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score". , 2018, Atherosclerosis.
[24] B. Zafrir,et al. Clinical features and outcomes of severe, very severe, and extreme hypertriglyceridemia in a regional health service. , 2018, Journal of clinical lipidology.
[25] J. E. Roeters van Lennep,et al. The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study. , 2018, Journal of clinical lipidology.
[26] W. Karmally,et al. Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span. , 2018, Journal of clinical lipidology.
[27] Prashanth Rawla,et al. Hypertriglyceridemia-induced pancreatitis: updated review of current treatment and preventive strategies , 2018, Clinical Journal of Gastroenterology.
[28] M. Bellgard,et al. The role of patient registries for rare genetic lipid disorders , 2018, Current opinion in lipidology.
[29] D. Gaudet,et al. Roundtable discussion: Familial chylomicronemia syndrome: Diagnosis and management. , 2018, Journal of clinical lipidology.
[30] E. Schaefer,et al. Differential Effects of Estrogen and Progestin on Apolipoprotein B100 and B48 Kinetics in Postmenopausal Women. , 2018, Lipids.
[31] D. Gaudet,et al. Roundtable on etiology of familial chylomicronemia syndrome. , 2017, Journal of clinical lipidology.
[32] A. Remaley,et al. Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism. , 2017, Atherosclerosis.
[33] S. Bertolini,et al. Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride. , 2017, Journal of Clinical Lipidology.
[34] M. Okubo,et al. Severe hypertriglyceridemia in Japan: Differences in causes and therapeutic responses. , 2017, Journal of clinical lipidology.
[35] G. Cooper,et al. Case of familial hyperlipoproteinemia type III hypertriglyceridemia induced acute pancreatitis: Role for outpatient apheresis maintenance therapy , 2017, World journal of gastroenterology.
[36] Alan S. Brown,et al. The burden of familial chylomicronemia syndrome from the patients’ perspective , 2017, Expert review of cardiovascular therapy.
[37] D. Gaudet,et al. Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia. , 2017, Circulation.
[38] G. Iotti,et al. The role of registries in rare genetic lipid disorders: Review and introduction of the first global registry in lipoprotein lipase deficiency. , 2017, Atherosclerosis.
[39] Tanya M. Teslovich,et al. Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease , 2017, The New England journal of medicine.
[40] D. Gaudet,et al. Clinical and biochemical features of different molecular etiologies of familial chylomicronemia. , 2017, Journal of clinical lipidology.
[41] S. Young,et al. Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia , 2017, The New England journal of medicine.
[42] Z. Ahmad,et al. Building a better understanding of the burden of disease in familial chylomicronemia syndrome , 2017, Expert review of clinical pharmacology.
[43] Yin Zhu,et al. Emergent Triglyceride-lowering Therapy With Early High-volume Hemofiltration Against Low–Molecular-Weight Heparin Combined With Insulin in Hypertriglyceridemic Pancreatitis: A Prospective Randomized Controlled Trial , 2016, Journal of clinical gastroenterology.
[44] N. Patni,et al. Type 1 hyperlipoproteinemia in a child with large homozygous deletion encompassing GPIHBP1. , 2016, Journal of clinical lipidology.
[45] H. Pitt,et al. Systematic review of hypertriglyceridemia-induced acute pancreatitis: A more virulent etiology? , 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[46] N. Rashid,et al. Severe hypertriglyceridemia and factors associated with acute pancreatitis in an integrated health care system. , 2016, Journal of clinical lipidology.
[47] S. Bertolini,et al. Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene. , 2016, Journal of clinical lipidology.
[48] D. Gaudet,et al. Acute Pancreatitis is Highly Prevalent and Complications can be Fatal in Patients with Familial Chylomicronemia: Results From a Survey of Lipidologist , 2016 .
[49] Curuchi P Anand,et al. Acute pancreatitis with normal amylase and lipase--an ED dilemma. , 2016, The American journal of emergency medicine.
[50] D. Wilson,et al. Editorial commentary: Dietary management of familial chylomicronemia syndrome. , 2016, Journal of clinical lipidology.
[51] D. Simons-Morton,et al. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report , 2016, Pediatric Clinical Practice Guidelines & Policies.
[52] B. Nordestgaard,et al. Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency. , 2016, Journal of clinical lipidology.
[53] Salik Nazir,et al. Hypertriglyceridemic pancreatitis associated with confounding laboratory abnormalities , 2016, Journal of community hospital internal medicine perspectives.
[54] R. Hegele,et al. Novel therapeutics in hypertriglyceridemia , 2015, Current opinion in lipidology.
[55] G. Russi. Severe dyslipidemia in pregnancy: The role of therapeutic apheresis. , 2015, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[56] R. Lim,et al. Presentation and management of acute hypertriglyceridemic pancreatitis in pregnancy: A case report , 2015, Obstetric medicine.
[57] H. Nawaz,et al. Elevated Serum Triglycerides are Independently Associated With Persistent Organ Failure in Acute Pancreatitis , 2015, The American Journal of Gastroenterology.
[58] C. Meyers,et al. Pharmacokinetics, pharmacodynamics, safety, and tolerability of pradigastat, a novel diacylglycerol acyltransferase 1 inhibitor in overweight or obese, but otherwise healthy human subjects , 2015, Journal of clinical pharmacology.
[59] T. Ooi,et al. Severe gestational hypertriglyceridemia: A practical approach for clinicians , 2015, Obstetric medicine.
[60] W. Jehangir,et al. Hypertriglyceridemia-Induced Pancreatitis: Choice of Treatment , 2015, Gastroenterology research.
[61] D. Yadav,et al. The role of apheresis in hypertriglyceridemia-induced acute pancreatitis: A systematic review. , 2015, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[62] K. Hayashi,et al. Clinical characteristics of Japanese patients with severe hypertriglyceridemia. , 2015, Journal of clinical lipidology.
[63] Mengtao Zhou,et al. Genetic Variants Associated with Gestational Hypertriglyceridemia and Pancreatitis , 2015, PloS one.
[64] R. Hegele,et al. Chylomicronaemia—current diagnosis and future therapies , 2015, Nature Reviews Endocrinology.
[65] U. Julius,et al. Treatment of primary hypertriglyceridemia states--General approach and the role of extracorporeal methods. , 2015, Atherosclerosis. Supplements.
[66] S. Young,et al. JCL Roundtable: Hypertriglyceridemia due to defects in lipoprotein lipase function. , 2015, Journal of clinical lipidology.
[67] D. Gaudet,et al. Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome , 2015, Lipids in Health and Disease.
[68] David M. Herrington,et al. Multiple rare alleles at LDLR and APOA5 confer risk for early-onset myocardial infarction , 2014, Nature.
[69] K. Higuchi,et al. Clinical and economic outcomes in a real-world population of patients with elevated triglyceride levels. , 2014, Atherosclerosis.
[70] N. Ewald,et al. Current knowledge of hypertriglyceridemic pancreatitis. , 2014, European journal of internal medicine.
[71] J. Blankstein,et al. Severe Hypertriglyceridemia Induced Pancreatitis in Pregnancy , 2014, Case reports in obstetrics and gynecology.
[72] A. Garg,et al. Genotype-phenotype relationships in patients with type I hyperlipoproteinemia. , 2014, Journal of clinical lipidology.
[73] D. Gaudet,et al. Association of CTRC and SPINK1 gene variants with recurrent hospitalizations for pancreatitis or acute abdominal pain in lipoprotein lipase deficiency , 2014, Front. Genet..
[74] H. Tornqvist,et al. Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial , 2014, Diabetes, obesity & metabolism.
[75] G. Saade,et al. Familial hypertriglyceridemia in pregnancy , 2014, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[76] K. Wenner,et al. Homozygosity for a partial deletion of apoprotein A-V signal peptide results in intracellular missorting of the protein and chylomicronemia in a breast-fed infant. , 2014, Atherosclerosis.
[77] D. Yadav,et al. Issues in hypertriglyceridemic pancreatitis: an update. , 2014, Journal of clinical gastroenterology.
[78] F. Sacks,et al. Severe hypertriglyceridemia with pancreatitis: thirteen years' treatment with lomitapide. , 2014, JAMA internal medicine.
[79] A. Coomarasamy,et al. Pre‐eclampsia is associated with, and preceded by, hypertriglyceridaemia: a meta‐analysis , 2013, BJOG : an international journal of obstetrics and gynaecology.
[80] R. Hegele,et al. Western Database of Lipid Variants (WDLV): a catalogue of genetic variants in monogenic dyslipidemias. , 2013, Canadian Journal of Cardiology.
[81] S. Lai,et al. Severe Hypertriglyceridemia‐Related Acute Pancreatitis , 2013, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[82] James L. Netterville,et al. Clinical Practice Guideline , 2013, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[83] A. Wierzbicki,et al. Lipid-Lowering Agents , 2013, Journal of cardiovascular pharmacology and therapeutics.
[84] Mark E. Williams,et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue , 2013, Journal of clinical apheresis.
[85] R. Başar,et al. Therapeutic apheresis for severe hypertriglyceridemia in pregnancy , 2013, Archives of Gynecology and Obstetrics.
[86] Weihong Xu,et al. Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat. , 2013, Journal of clinical lipidology.
[87] T. MacDonald,et al. Hypertriglyceridemia and acute pancreatitis. , 2013, JAMA internal medicine.
[88] D. Gaudet,et al. Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study , 2013, The Lancet.
[89] Robert V Farese,et al. DGAT1 mutation is linked to a congenital diarrheal disorder. , 2012, The Journal of clinical investigation.
[90] B. Arondekar,et al. Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemia. , 2012, Journal of clinical lipidology.
[91] W. Kraus,et al. Exercise effects on lipids in persons with varying dietary patterns-does diet matter if they exercise? Responses in Studies of a Targeted Risk Reduction Intervention through Defined Exercise I. , 2012, American heart journal.
[92] Karine Tremblay,et al. Efficacy and long term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open label trial , 2012, Gene Therapy.
[93] H. Kloer,et al. Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis , 2012 .
[94] R. Hegele,et al. Severe hypertriglyceridemia in pregnancy. , 2012, The Journal of clinical endocrinology and metabolism.
[95] P. Schuff-Werner,et al. Role of lipid apheresis in changing times , 2012, Clinical Research in Cardiology Supplements.
[96] H. Kloer,et al. Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis , 2012, Clinical Research in Cardiology Supplements.
[97] D. Mikhailidis,et al. Acute pancreatitis in pregnancy: an overview. , 2011, European journal of obstetrics, gynecology, and reproductive biology.
[98] J. DeLany,et al. Lipotoxicity Causes Multisystem Organ Failure and Exacerbates Acute Pancreatitis in Obesity , 2011, Science Translational Medicine.
[99] Jonathan C. Cohen,et al. Deletion of GPIHBP1 causing severe chylomicronemia , 2011, Journal of Inherited Metabolic Disease.
[100] Weiqin Li,et al. Severe Acute Pancreatitis During Pregnancy: Eleven Years Experience from a Surgical Intensive Care Unit , 2011, Digestive Diseases and Sciences.
[101] T. Mollnes,et al. Selective whole blood lipoprotein apheresis to prevent pancreatitis in drug refractory hypertriglyceridemia. , 2010, JOP : Journal of the pancreas.
[102] D. Gaudet,et al. Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency. , 2010, Atherosclerosis. Supplements.
[103] M. Elisaf,et al. The Effects of Ezetimibe and/or Orlistat on Triglyceride-Rich Lipoprotein Metabolism in Obese Hypercholesterolemic Patients , 2010, Lipids.
[104] S. Young,et al. Chylomicronemia With Low Postheparin Lipoprotein Lipase Levels in the Setting of GPIHBP1 Defects , 2010, Circulation. Cardiovascular genetics.
[105] D. Whitcomb. Genetic aspects of pancreatitis. , 2010, Annual review of medicine.
[106] Joseph L Goldstein,et al. LXR-SREBP-1c-Phospholipid Transfer Protein Axis Controls Very Low Density Lipoprotein (VLDL) Particle Size* , 2009, The Journal of Biological Chemistry.
[107] P. Hardt,et al. Severe hypertriglyceridemia and pancreatitis: presentation and management , 2009, Current opinion in lipidology.
[108] G. Labbadia,et al. Therapeutic plasma exchange in patients with severe hypertriglyceridemia: a multicenter study. , 2009, Artificial organs.
[109] H. Katabuchi,et al. Hypertriglyceridemic acute pancreatitis during pregnancy: prevention with diet therapy and omega-3 fatty acids in the following pregnancy. , 2009, Nutrition.
[110] M. Taskinen,et al. Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia. , 2009, The Journal of clinical endocrinology and metabolism.
[111] C. Nelson-Piercy,et al. Severe hypertriglyceridemia complicating pregnancy, management by dietary intervention and omega-3 fatty acid supplementation. , 2009, Nutrition.
[112] C. Férec,et al. Chronic pancreatitis: genetics and pathogenesis. , 2009, Annual review of genomics and human genetics.
[113] U. Navaneethan,et al. Hypertriglyceridemic Pancreatitis: Presentation and Management , 2009, The American Journal of Gastroenterology.
[114] A. Başaran. Pregnancy-induced Hyperlipoproteinemia: Review of the Literature , 2009, Reproductive Sciences.
[115] M. Hayden,et al. Acute hypertriglyceridemic pancreatitis during pregnancy due to homozygous lipoprotein lipase gene mutation. , 2009, Clinica chimica acta; international journal of clinical chemistry.
[116] B. Dong,et al. Association of Cognitive Impairment with Serum Lipid/Lipoprotein among Chinese Nonagenarians and Centenarians , 2009, Dementia and Geriatric Cognitive Disorders.
[117] P. Hardt,et al. Successful Long-Term Treatment of Severe Hypertriglyceridemia by Feedback Control with Lipid Self-Monitoring , 2008, Annals of Nutrition and Metabolism.
[118] P. Pajukanta,et al. Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia , 2007, Nature Genetics.
[119] R. Hegele,et al. Hypertriglyceridemia: its etiology, effects and treatment , 2007, Canadian Medical Association Journal.
[120] S. Young,et al. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. , 2007, Cell metabolism.
[121] S. Tonstad,et al. Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia. , 2006, Atherosclerosis.
[122] I. Usta,et al. Recurrent hypertriglyceridemia-induced pancreatitis in pregnancy: a management dilemma. , 2006, Pancreas.
[123] Masahiro Yoshida,et al. JPN Guidelines for the management of acute pancreatitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis , 2006, Journal of hepato-biliary-pancreatic surgery.
[124] H. Mabuchi,et al. Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis. , 2005, The Journal of clinical endocrinology and metabolism.
[125] L. Pennacchio,et al. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. , 2005, The Journal of clinical investigation.
[126] J. Heeren,et al. Give me A5 for lipoprotein hydrolysis! , 2005, The Journal of clinical investigation.
[127] N. Mikhail,et al. Treatment of severe hypertriglyceridemia in nondiabetic patients with insulin. , 2005, The American journal of emergency medicine.
[128] L. Pennacchio,et al. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. , 2005, The Journal of biological chemistry.
[129] G. Olivecrona,et al. Rapid Subunit Exchange in Dimeric Lipoprotein Lipase and Properties of the Inactive Monomer* , 2004, Journal of Biological Chemistry.
[130] M. Barmada,et al. Clinical characterization of patients with idiopathic chronic pancreatitis and SPINK1 Mutations , 2004, Scandinavian journal of gastroenterology.
[131] Takashi Suzuki,et al. Expression Cloning and Characterization of a Novel Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein, GPI-HBP1* , 2003, The Journal of Biological Chemistry.
[132] E. Herrera. Lipid metabolism in pregnancy and its consequences in the fetus and newborn , 2002, Endocrine.
[133] N. Nikolaidis,et al. Long-term Follow-up of Patients With Acute Hypertriglyceridemia-Induced Pancreatitis , 2002, Journal of clinical gastroenterology.
[134] R. Hegele,et al. Successful pregnancy outcome in a patient with severe chylomicronemia due to compound heterozygosity for mutant lipoprotein lipase. , 2002, Clinical biochemistry.
[135] M. Adachi,et al. No evidence of accelerated atherosclerosis in a 66-yr-old chylomicronemia patient homozygous for the nonsense mutation (Tyr61-->stop) in the lipoprotein lipase gene. , 2001, Atherosclerosis.
[136] J. Frohlich,et al. Lipoprotein lipase and apoE polymorphisms: relationship to hypertriglyceridemia during pregnancy. , 2001, Journal of lipid research.
[137] Jonathan C. Cohen,et al. An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing , 2001, Science.
[138] H. Fred,et al. Images in clinical medicine. Lipemia retinalis. , 1999, The New England journal of medicine.
[139] M. Knowles,et al. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. , 1998, The New England journal of medicine.
[140] N. Matsumura,et al. Prevention of hyperlipidemic acute pancreatitis during pregnancy with medium-chain triglyceride nutritional support , 1998, International journal of pancreatology : official journal of the International Association of Pancreatology.
[141] N. Tamasawa,et al. Identification of homozygous lipoprotein lipase gene mutation in a woman with recurrent aggravation of hypertriglyceridaemia induced by pregnancy , 1998, Journal of internal medicine.
[142] D. Müller-Wieland,et al. A single nucleotide substitution in the promoter region of the apolipoprotein C-II gene identified in individuals with chylomicronemia. , 1996, Journal of lipid research.
[143] M. Hayden,et al. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. , 1996, The New England journal of medicine.
[144] C. Berkelhammer,et al. Plasma exchange for dramatic gestational hyperlipidemic pancreatitis. , 1996, Journal of clinical gastroenterology.
[145] C. Glueck,et al. Treatment of severe familial hypertriglyceridemia during pregnancy with very-low-fat diet and n-3 fatty acids. , 1996, Nutrition.
[146] M. A. Lasunción,et al. Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women. , 1996, Journal of lipid research.
[147] E. Cavallero,et al. Prevention of Recurrent Acute Pancreatitis in Patients with Severe Hypertriglyceridemia: Value of Regular Plasmapheresis , 1994, Pancreas.
[148] D. Mastrogiannis,et al. Maternal hyperlipidemia in pregnancy. , 1994, Clinical obstetrics and gynecology.
[149] S. Eisenberg,et al. Continuous intravenous heparin administration in humans causes a decrease in serum lipolytic activity and accumulation of chylomicrons in circulation. , 1994, Journal of lipid research.
[150] M. Hayden,et al. Gene-environment interaction in the conversion of a mild-to-severe phenotype in a patient homozygous for a Ser172-->Cys mutation in the lipoprotein lipase gene. , 1993, The Journal of clinical investigation.
[151] B. Lewis,et al. Management of patients with severe hypertriglyceridaemia during pregnancy: report of two cases with familial lipoprotein lipase deficiency , 1992, British journal of obstetrics and gynaecology.
[152] P. Malfertheiner,et al. Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease. , 1991, International journal of pancreatology : official journal of the International Association of Pancreatology.
[153] R. Gregg,et al. Donor splice site mutation in the apolipoprotein (Apo) C-II gene (Apo C-IIHamburg) of a patient with Apo C-II deficiency. , 1988, The Journal of clinical investigation.
[154] H. Brewer,et al. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. , 1983, The Journal of clinical endocrinology and metabolism.
[155] A. Postle,et al. Lipid metabolism in pregnancy , 1982, British journal of obstetrics and gynaecology.
[156] J. Riemann,et al. [Acute pancreatitis in pregnancy]. , 1981, Die Medizinische Welt.
[157] A. Yamamoto,et al. Familial type I hyperlipoproteinemia caused by apolipoprotein C-II deficiency. , 1979, Atherosclerosis.
[158] P. Nestel,et al. The hyperlipidemia of pregnancy in normal and complicated pregnancies. , 1979, American journal of obstetrics and gynecology.
[159] J. Little,et al. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. , 1978, The New England journal of medicine.
[160] W. Blackwelder,et al. Primary type V hyperlipoproteinemia. A descriptive study in 32 families. , 1977, Annals of internal medicine.
[161] P. Nilsson-ehle,et al. A stable, radioactive substrate emulsion for assay of lipoprotein lipase. , 1976, Journal of lipid research.
[162] R. Knopp,et al. Lipid metabolism in pregnancy. II. Altered lipid composition in intermediage, very low, low and high-density lipoprotein fractions. , 1975, The Journal of clinical endocrinology and metabolism.
[163] C. Glueck,et al. Suppression of amylase activity by hypertriglyceridemia. , 1973, JAMA.
[164] D. Porte,et al. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. , 1973, The Journal of clinical investigation.
[165] W. Connor,et al. The different effects on the serum lipids and fecal steroids of high carbohydrate diets given orally or intravenously. , 1973, The Journal of clinical investigation.
[166] E. Nikkilä,et al. Plasma triglyceride turnover during use of oral contraceptives. , 1971, Metabolism: clinical and experimental.
[167] Alan S. Brown,et al. Extreme hypertriglyceridemia: Genetic diversity, pancreatitis, pregnancy, and prevalence. , 2019, Journal of clinical lipidology.
[168] R. Hegele,et al. Severe hypertriglyceridemia is primarily polygenic. , 2019, Journal of clinical lipidology.
[169] E. Stroes,et al. Diagnostic algorithm for familial chylomicronemia syndrome. , 2017, Atherosclerosis Supplements.
[170] L. Hemphill,et al. Lipoprotein Apheresis. , 2016, Endocrinology and metabolism clinics of North America.
[171] M. Okubo,et al. Apolipoprotein C-II Tuzla: a novel large deletion in APOC2 caused by Alu-Alu homologous recombination in an infant with apolipoprotein C-II deficiency. , 2015, Clinica chimica acta; international journal of clinical chemistry.
[172] R. Horwitz,et al. Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia. , 2014, The American journal of medicine.
[173] Martina Heim,et al. [Severe hypertriglyceridemia]. , 2013, Praxis.
[174] Y. Izumida,et al. Apolipoprotein C-II deficiency with no rare variant in the APOC2 gene. , 2013, Journal of atherosclerosis and thrombosis.
[175] L. Volpe,et al. Triglyceride metabolism in pregnancy. , 2011, Advances in clinical chemistry.
[176] D. Gaudet,et al. Etiology and risk of lactescent plasma and severe hypertriglyceridemia. , 2011, Journal of clinical lipidology.
[177] W. Banks,et al. Lipids and cognition. , 2010, Journal of Alzheimer's disease : JAD.
[178] J. Danesh,et al. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies , 2010, The Lancet.
[179] K. Gregory,et al. Management of familial hypertriglyceridemia during pregnancy with plasma exchange , 2009, Journal of clinical apheresis.
[180] E. Leitersdorf,et al. Long‐term plasma exchange for severe refractory hypertriglyceridemia: A decade of experience demonstrates safety and efficacy , 2009, Journal of clinical apheresis.
[181] J. Greenberg,et al. Omega-3 Fatty Acid supplementation during pregnancy. , 2008, Reviews in obstetrics & gynecology.
[182] V. Sapin,et al. [Management of gestational hypertriglyceridemia by plasmapheresis]. , 2007, Gynecologie, obstetrique & fertilite.
[183] Keshav R. Nayak,et al. Images in clinical medicine. Eruptive xanthomas associated with hypertriglyceridemia and new-onset diabetes mellitus. , 2004, The New England journal of medicine.
[184] 荏原 徹. No evidence of accelerated atherosclerosis in a 66-yr-old chylomicronemia patient homozygous for the nonsense mutation (Tyr61→Stop) in the lipoprotein lipase gene , 2002 .
[185] P. Reitsma,et al. Apolipoprotein A-V A NOVEL APOLIPOPROTEIN ASSOCIATED WITH AN EARLY PHASE OF LIVER REGENERATION* , 2001 .
[186] B. Hoogwerf,et al. Severe hypertriglyceridemia and acute pancreatitis during pregnancy: treatment with gemfibrozil. , 1999, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[187] S. Kihara,et al. Autoimmune hyperchylomicronemia. , 1989, The New England journal of medicine.
[188] R. Havel. Pathogenesis, differentiation and management of hypertriglyceridemia. , 1969, Advances in internal medicine.
[189] R. Lees,et al. A SYSTEM FOR PHENOTYPING HYPERLIPOPROTEINEMIA. , 1965, Circulation.